CLINICAL_TRIALS
withdrawal
· 2025-09-26
Clinical Trial Update: Metabiomics Colon Cancer Clinical Research Study
Summary
Metabiomics Corp's colon cancer clinical trial (NCT02151123) has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Metabiomics Corp | Conditions: Colonic Neoplasms | Status: WITHDRAWN